journal article·2021-04

DT-diaphorase triggered theranostic nanoparticles induce the self-burst of reactive oxygen species for tumor diagnosis and treatment

Dan Yan, Xiao Xu, Chunling Ren, Chen Chen, Jianguang Luo, Chao Han, Lingyi Kong

Acta Biomaterialia· Volume 125
Publisher page

Abstract

On-demand therapy following effective tumor detection would considerably reduce the side effects of traditional chemotherapy. DT-diaphorase (DTD), whose level is strongly elevated in various tumors, is a cytosolic flavoenzyme that promotes intracellular reactive oxygen species (ROS) generation via the redox cycling of hydroquinones. Incorporation of the DTD-responsive substrate to the structures of the probe and prodrug may facilitate the tumor detection and therapy. Herein, we established an multifunctional drug delivery nanosystem (HTLAC) that rapidly responds to the DTD enzyme, leads to the early-stage precise detection and termination of tumors. Firstly, the synthesis of DTD-responsive withaferin A (DT-WA) and indocyanine green (DT-Cy5) was performed. In the presence of DTD, WA, which produces ROS in cells, was released from DT-WA, and the red fluorescence of DT-Cy5 was detected for tumor imaging. Additionally, these DTD enzyme reaction processes of DT-WA and DT-Cy5 induced ROS. The self-burst of ROS generation by the two enzyme reaction processes as well as the released WA then led to the apoptosis of tumor cells. To increase the bioavailability and tumor targeting of drugs, cell-penetrating peptide and hyaluronic acid functionalized liposomes were used to encapsulate the drugs. The detailed in vitro and in vivo assays showed that HTLAC achieved enhanced tumor detection and superior antitumor efficiency. According to above outcomes, results showed that HTLAC might provide an efficacious approach for the fabrication of enzyme-triggering nanosystems to detect tumor and induce the self-burst of ROS for an efficient tumor treatment. STATEMENT OF SIGNIFICANCE: We have fabricated a HTLAC nanosystem to address the need of bursting reactive oxygen species (ROS) generation within tumor site. Our goal uniquely aims at not only augmentation of ROS-inducing anticancer efficacy, but also to meet the challenges of tumor dynamic detection in the clinical practices. In this work, the DT-diaphorase responsive withaferin A (DT-WA) and indocyanine green (DT-Cy5) are synthesized, and observed more specifically toward DTD under physiological conditions. As the cell-penetrating peptide and hyaluronic acid functionalized liposome, the HTLAC not only induces antiproliferative activity by generating self-burst of ROS, but also effectively accumulate and restore its fluorescence at the tumor site because of the HA actively targeting tumor along with the prolonged presence in blood circulation. Besides, this enzyme-triggering nanosystem exhibited an effective tumor inhibition with a low systemic toxicity.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (37)

Show source-provided references
1. pH-responsive self-healing injectable hydrogel based on n-carboxyethyl chitosan for hepatocellular carcinoma therapy10.1016/j.actbio.2017.06.001 ↗
2. A colorful chemotherapy agent could be made less toxic10.1126/science.369.6499.18 ↗
3. A nanostrategy for efficient imaging-guided antitumor therapy through a stimuli-responsive branched polymeric prodrug10.1002/advs.201903243 ↗
4. A dithiocarbamate-based H2O2-responsive prodrug for combinational chemotherapy and oxidative stress amplification therapy10.1039/C9CC05438C ↗
5. Highly stable, coordinated polymeric nanoparticles loading copper(II) diethyldithiocarbamate for combinational chemo/chemodynamic therapy of cancer10.1021/acs.biomac.9b00367 ↗
6. PEG-PLGA nanospheres loaded with nanoscintillators and photosensitizers for radiation-activated photodynamic therapy10.1016/j.actbio.2020.09.029 ↗
7. Tumor targeted self-synergistic nanoplatforms for arsenic-sensitized photodynamic therapy10.1016/j.actbio.2020.09.047 ↗
8. Tunable hydrophile–lipophile balance for manipulating structural stability and tumor retention of amphiphilic nanoparticles10.1002/adma.201901586 ↗
9. Multifunctional sonosensitizers in sonodynamic cancer therapy10.1039/C9CS00648F ↗
10. Newly developed strategies for improving sonodynamic therapy10.1039/D0MH00613K ↗
11. Recent advances in photonanomedicines for enhanced cancer photodynamic therapy10.1016/j.pmatsci.2020.100685 ↗
12. Targeted theranostics of lung cancer: PD-L1-guided delivery of gold nanoprisms with chlorin e6 for enhanced imaging and photothermal/photodynamic therapy10.1016/j.actbio.2020.09.040 ↗
13. Ultrasound-switchable nanozyme augments sonodynamic therapy against multidrug-resistant bacterial infection10.1021/acsnano.9b08667 ↗
14. MOF-derived double-layer hollow nanoparticles with oxygen generation ability for multimodal imaging-guided sonodynamic therapy10.1002/anie.202004894 ↗
15. NOX2-dependent reactive oxygen species regulate formyl-peptide receptor 1-mediated TrkA transactivation in SH-SY5Y Cells10.1155/2019/2051235 ↗
16. Enzyme targeting strategies for prevention and treatment of cancer: implications for cancer therapy10.1016/j.semcancer.2017.12.003 ↗
17. Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma10.1186/s13045-020-00979-y ↗
18. Carboxyl esterase-like activity of DT-diaphorase and its use for signal amplification10.1021/acssensors.9b01448 ↗
19. Design and synthesis of chiral and regenerable [2.2] paracyclophane-based NAD(P)H models and application in biomimetic reduction of flavonoids10.1039/D0SC04188B ↗
20. Conjugated oligomer-based ultrasensitive fluorescent biosensor for activatable imaging of endogenous nqo1 with high catalytic efficiency in cancer cells10.1016/j.snb.2020.127981 ↗
21. Esterase-activatable b-lapachone prodrug micelles for NQO1-targeted lung cancer therapy10.1016/j.jconrel.2014.12.027 ↗
22. NAD(P)H:quinone oxidoreductase 1 (NQO1) as a therapeutic and diagnostic target in cancer10.1021/acs.jmedchem.8b00124 ↗
23. Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway10.1038/srep29926 ↗
24. Downregulation of TIGAR sensitizes the antitumor effect of physapubenolide through increasing intracellular ROS levels to trigger apoptosis and autophagosome formation in human breast carcinoma cells10.1016/j.bcp.2017.07.018 ↗
25. Cellular target identification of withangulatin A using fluorescent analogues and subsequent chemical proteomics10.1039/C9CC03653A ↗
26. Target discovery of cytotoxic withanolides from Physalis angulata var.villosa via reactivity-based screening10.1016/j.jpba.2017.12.047 ↗
27. Design and SAR of withangulatin A analogues that act as covalent TrxR inhibitors through the michael addition reaction showing potential in cancer treatment10.1021/acs.jmedchem.0c01128 ↗
28. Identification of withaferin A as a potential candidate for anti-cancer therapy in non-small cell lung cancer10.3390/cancers11071003 ↗
29. Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells10.1016/j.canlet.2014.11.026 ↗
30. Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents10.1016/j.ejmech.2020.112396 ↗
31. Deoxynyboquinones as NQO1-activated cancer therapeutics10.1021/acs.accounts.5b00365 ↗
32. Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment10.1038/ncomms5280 ↗
33. Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells10.2147/IJN.S170274 ↗
34. A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy10.1016/j.jconrel.2017.08.032 ↗
35. Implantable hyaluronic acid-deferoxamine conjugate prevents nonunions through stimulation of neovascularization10.1038/s41536-019-0072-9 ↗
36. A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy10.1039/C5CC02149A ↗
37. Detection and cellular imaging of human cancer enzyme using a turn-on, wavelength-shiftable, self-immolative profluorophore10.1021/ja5030707 ↗